RecruitingNCT05837221

Microbiome in Head and Neck Squamous Cell Carcinoma

Role of Human Microbiome in Head and Neck Cancer


Sponsor

University of Colorado, Denver

Enrollment

60 participants

Start Date

May 23, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to determine whether dysbiosis actively contributes to HNSCC and if so, the underlying molecular mechanisms.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria5

  • Subjects equal to or above the age of 18.
  • Patients who are seen and evaluated by a provider within the adult Otolaryngology clinic at the University of Colorado Health.
  • Patients that present with a diagnosis of OSCC.
  • An equal number of age-matched patients who are visiting the clinic for reasons other than OSCC diagnoses, as the control group.
  • Ability to understand and willingness to sign a written informed consent document

Exclusion Criteria2

  • Subjects under the age of 18 or over the age of 100
  • Subjects unwilling to particiapte

Interventions

DIAGNOSTIC_TESTMetagenomic sequencing

Shotgun metagenomic sequencing will characterize cancer-associated changes in microbial functional capacity and species/strain-level taxonomic profiles. Metagenomics will provide data on microbial functional capacity along with broader taxonomic classifications.

DIAGNOSTIC_TESTMetabolic analysis

Metabolic analysis will be conducted using LC/MS-based metabolic analysis. A targeted approach will quantify a panel of 30 compounds including Trp pathway products while a non-targeted approach, when applied to both lipid and aqueous phase compounds, will profile relative changes in compounds that may influence host


Locations(1)

University of Colorado Cancer Center

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05837221


Related Trials